Physician profile
John H Lee
NPI 1316915366
$1,206.16
in general payments reported to CMS, 2019-2025
14 companies · $362 in 2025
The $362 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.52 · 2020: $14.41 · 2021: $71.34 · 2022: $68.26 · 2023: $53.40 · 2024: $554 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Travel and Lodging: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.51 |
| Travel and Lodging | $285.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $575.71 | 2024-2025 | Ensite, Aveir, Diamondback Coronary |
| Abbvie INC. | $116.00 | 2025 | |
| Boston Scientific Corporation | $105.47 | 2020-2025 | Watchman Flx, Watchman Access System |
| Abiomed | $83.56 | 2022-2024 | Impella |
| Inari Medical, INC. | $71.81 | 2019-2021 | |
| Cardiovascular Systems INC. | $70.99 | 2019 | |
| Stryker Corporation | $34.77 | 2025 | Flowtriever, Artix Mt |
| Medtronic, INC. | $31.15 | 2023-2025 | Capsurefix Novus Mri Surescan, Mo.Ma Ultra |
| Terumo Medical Corporation | $28.70 | 2022-2025 | Metacross Otw, Tr Band |
| Daxor Corporation | $22.41 | 2024 | Bva-100 |
| Shockwave Medical, INC | $20.00 | 2022 | |
| Opsens INC. | $17.82 | 2022 | |
| Bard Peripheral Vascular, INC. | $15.71 | 2023 | Crosser Iq |
| Livanova USA, INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.